-
StreetInsider.com Pre-Open Movers 4/15: (S) (LIFE) (NFP) Higher; (SLW) (ABX) (CLWR) Lower (more...)
-
Citi Upgrades Acorda Therapeutics, Inc. (ACOR) to Buy
-
Pre-Open Movers 10/02: (CTIC) (INVE) (ILMN) Higher; (ARQL) (EXPR) (CLB) Lower (more...)
-
Citi Downgrades Acorda Therapeutics, Inc. (ACOR) to Neutral, Raises Price Target to $29
-
Citi Upgrades Acorda Therapeutics, Inc. (ACOR) to Buy
-
Acorda (ACOR) Ticks Higher On New "Hold" Rating Which Discounts M&A Talk
-
Citi Starts Acorda Therapeutics (ACOR) at Hold, $39 Price Target
-
Morning Movers 10/15: ACOR, SLTM, RUBO, DSW, CIT, PLX Higher; STSA, UEC, CXM, CHIO, MNI Lower
-
Morning Movers 3/31: AMLN, TBSI, FUQI, TXT, STSI Higher; TLCV, ACOR, ALTH, OXM, HIG Lower
-
Pre-Open Movers 6/2: Acorda (ACOR) Up on Positive Drug Data; Harris (HRS) Lower After Saying No Sale
-
Notable Analyst Rating Changes 2/21: CSCO, GRMN, RIG Upgraded; TGT, LAD, BP, PT Downgraded
-
Summary of Atticus Capital's 13F; New Stakes In Baidu, Nymex and Boeing (BIDU, NMX & BA)
-
Pre-Open Movers 1/28: Alliance Data (ADS) Sinks As Blackstone Walks; LNY, MATR, NYX Up on Buyout News